Published in Br J Radiol on February 12, 2013
Clinical Application of High-intensity Focused Ultrasound in Cancer Therapy. J Cancer (2016) 0.81
Efficient intracellular delivery of molecules with high cell viability using nanosecond-pulsed laser-activated carbon nanoparticles. ACS Nano (2014) 0.78
Extracorporeal ultrasound-guided high intensity focused ultrasound: implications from the present clinical trials. ScientificWorldJournal (2014) 0.77
Portable high-intensity focused ultrasound system with 3D electronic steering, real-time cavitation monitoring, and 3D image reconstruction algorithms: a preclinical study in pigs. Ultrasonography (2014) 0.75
High intensity focused ultrasound inhibits melanoma cell migration and metastasis through attenuating microRNA-21-mediated PTEN suppression. Oncotarget (2016) 0.75
Ultrasound-guided trans-rectal high-intensity focused ultrasound (HIFU) for advanced cervical cancer ablation is feasible: a case report. J Ther Ultrasound (2015) 0.75
Low-intensity continuous ultrasound triggers effective bisphosphonate anticancer activity in breast cancer. Sci Rep (2015) 0.75
Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys (1984) 6.22
Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study. Lancet Oncol (2012) 6.09
Transcranial magnetic resonance imaging- guided focused ultrasound surgery of brain tumors: initial findings in 3 patients. Neurosurgery (2010) 3.15
Controlled vesicle deformation and lysis by single oscillating bubbles. Nature (2003) 2.86
High intensity focused ultrasound: surgery of the future? Br J Radiol (2003) 2.66
MR imaging-guided focused ultrasound surgery of fibroadenomas in the breast: a feasibility study. Radiology (2001) 2.54
Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization. Radiology (2005) 2.34
Feasibility of US-guided high-intensity focused ultrasound treatment in patients with advanced pancreatic cancer: initial experience. Radiology (2005) 2.12
High-intensity focused ultrasound for prostate cancer: a systematic review. Clin Oncol (R Coll Radiol) (2010) 2.02
High-intensity focused ultrasound ablation in hepatic and pancreatic cancer: complications. Abdom Imaging (2011) 2.01
Thresholds for transient cavitation produced by pulsed ultrasound in a controlled nuclei environment. J Acoust Soc Am (1990) 2.00
High power transcranial beam steering for ultrasonic brain therapy. Phys Med Biol (2003) 1.87
High-intensity focused ultrasound: current potential and oncologic applications. AJR Am J Roentgenol (2008) 1.86
Pain palliation in patients with bone metastases using MR-guided focused ultrasound surgery: a multicenter study. Ann Surg Oncol (2008) 1.85
High-intensity focused ultrasound for hepatocellular carcinoma: a single-center experience. Ann Surg (2011) 1.79
Acoustic cavitation generated by an extracorporeal shockwave lithotripter. Ultrasound Med Biol (1987) 1.61
A theoretical assessment of the relative performance of spherical phased arrays for ultrasound surgery. IEEE Trans Ultrason Ferroelectr Freq Control (2000) 1.59
High intensity focused ultrasound in clinical tumor ablation. World J Clin Oncol (2011) 1.55
The threshold for brain damage in rabbits induced by bursts of ultrasound in the presence of an ultrasound contrast agent (Optison). Ultrasound Med Biol (2003) 1.53
A 256-element ultrasonic phased array system for the treatment of large volumes of deep seated tissue. IEEE Trans Ultrason Ferroelectr Freq Control (1999) 1.37
The evolving non-surgical ablation of breast cancer: MR guided focused ultrasound (MRgFUS). Breast Cancer (2007) 1.33
Extracorporeal high intensity focused ultrasound treatment for patients with breast cancer. Breast Cancer Res Treat (2005) 1.33
Concurrent gemcitabine and high-intensity focused ultrasound therapy in patients with locally advanced pancreatic cancer. Anticancer Drugs (2010) 1.27
Non-invasive transcranial ultrasound therapy based on a 3D CT scan: protocol validation and in vitro results. Phys Med Biol (2009) 1.23
Early clinical experience using high intensity focused ultrasound for palliation of inoperable pancreatic cancer. JOP (2009) 1.23
Feasibility of magnetic resonance imaging-guided focused ultrasound surgery as an adjunct to tamoxifen therapy in high-risk surgical patients with breast carcinoma. J Vasc Interv Radiol (2003) 1.23
Review article: high intensity focused ultrasound--potential for cancer treatment. Br J Radiol (1995) 1.22
High-intensity focused ultrasound as salvage therapy for patients with recurrent prostate cancer after external beam radiation, brachytherapy or proton therapy. BJU Int (2010) 1.22
HIFU for palliative treatment of pancreatic cancer. J Gastrointest Oncol (2011) 1.20
High-intensity focused ultrasound ablation: effective and safe therapy for solid tumors in difficult locations. AJR Am J Roentgenol (2010) 1.19
High-intensity focused ultrasound in patients with late-stage pancreatic carcinoma. Chin Med J (Engl) (2002) 1.16
Non-invasive opening of BBB by focused ultrasound. Acta Neurochir Suppl (2003) 1.16
Focal salvage therapy for localized prostate cancer recurrence after external beam radiotherapy: a pilot study. Cancer (2012) 1.11
"Wide local ablation" of localized breast cancer using high intensity focused ultrasound. J Surg Oncol (2007) 1.09
A random phased array device for delivery of high intensity focused ultrasound. Phys Med Biol (2009) 1.07
Primary bone malignancy: effective treatment with high-intensity focused ultrasound ablation. Radiology (2010) 1.07
A novel approach to energy ablative therapy of small renal tumours: laparoscopic high-intensity focused ultrasound. Eur Urol (2007) 1.07
Extracorporeal high intensity focused ultrasound for renal tumours: a 3-year follow-up. BJU Int (2010) 1.05
Preliminary experience using high intensity focused ultrasound for the treatment of patients with advanced stage renal malignancy. J Urol (2003) 1.05
Analgesic effect of high intensity focused ultrasound therapy for unresectable pancreatic cancer. Int J Hyperthermia (2011) 1.04
MR-guided adaptive focusing of therapeutic ultrasound beams in the human head. Med Phys (2012) 1.04
Ablation of superficial bladder tumors with focused extracorporeal pyrotherapy. Urology (1996) 1.03
The new surgery. Br Med J (Clin Res Ed) (1988) 1.03
Design and characterization of a laterally mounted phased-array transducer breast-specific MRgHIFU device with integrated 11-channel receiver array. Med Phys (2012) 1.01
Combination of thermal and cavitation effects to generate deep lesions with an endocavitary applicator using a plane transducer: ex vivo studies. Ultrasound Med Biol (2004) 1.01
Extracorporeal ablation of liver tissue by high-intensity focused ultrasound. Oncology (1993) 0.98
Design and optimization of an aperiodic ultrasound phased array for intracavitary prostate thermal therapies. Med Phys (1996) 0.97
Salvage HIFU for recurrent prostate cancer after radiotherapy. Prostate Cancer Prostatic Dis (2008) 0.97
Focused ultrasound as a local therapy for liver cancer. Cancer J (2010) 0.97
Superparamagnetic PLGA-iron oxide microcapsules for dual-modality US/MR imaging and high intensity focused US breast cancer ablation. Biomaterials (2012) 0.96
Ultrasound-based combination therapy: potential in urologic cancer. Expert Rev Anticancer Ther (2011) 0.95
HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study. Urol Oncol (2011) 0.93
Transrectal high-intensity focused ultrasonography is feasible as a new therapeutic option for advanced recurrent rectal cancer: report on the first case worldwide. Ann R Coll Surg Engl (2011) 0.92
High-intensity focused ultrasound combined with transarterial chemoembolization for unresectable hepatocellular carcinoma: long-term follow-up and clinical analysis. Eur J Radiol (2010) 0.91
High intensity focused ultrasound with large aperture transducers: a MRI based focal point correction for tissue heterogeneity. Med Phys (2012) 0.91
High-intensity focused ultrasound for the treatment of renal masses: current status and future potential. Curr Opin Urol (2009) 0.90
High-intensity focused ultrasound therapy for prostate cancer. Int J Urol (2011) 0.88
Hyperthermia in cancer treatment. Invest Radiol (1990) 0.87
Ultrasound therapy transducers with space-filling non-periodic arrays. IEEE Trans Ultrason Ferroelectr Freq Control (2011) 0.85
Focused extracorporeal pyrotherapy: experimental study and feasibility in man. Semin Urol (1993) 0.85
Real-time monitoring of high-intensity focused ultrasound ablations with photoacoustic technique: an in vitro study. Med Phys (2011) 0.84
Image-guided 256-element phased-array focused ultrasound surgery. IEEE Eng Med Biol Mag (2008) 0.84
Thermal effects of focused ultrasound energy on bone tissue. Ultrasound Med Biol (2001) 0.83
Ultrasound- and MR-guided focused ultrasound surgery for prostate cancer. World J Radiol (2012) 0.81
Laparoscopic high-intensity focused ultrasound for renal tumours: a proof of concept study. BJU Int (2010) 0.81
The utility of sparse 2D fully electronically steerable focused ultrasound phased arrays for thermal surgery: a simulation study. Phys Med Biol (2011) 0.81
Treatment with high intensity focused ultrasound: secrets revealed. Eur J Radiol (2011) 0.79
Prostate cancer therapy with high-intensity focused ultrasound. Clin Genitourin Cancer (2005) 0.78
Molecular MR imaging and MR-guided ultrasound therapies in cancer. JBR-BTR (2009) 0.76
Observations of ultrasound-induced effects in the fish Xiphophorous maculatus. Ultrasound Med Biol (1983) 0.76
Temperature distributions during clinical scanned, focused ultrasound hyperthermia treatments. Int J Hyperthermia (1991) 0.76
Respiration-induced movement correlation for synchronous noninvasive renal cancer surgery. IEEE Trans Ultrason Ferroelectr Freq Control (2012) 0.76
Surgical management of localised renal cell carcinoma. Cochrane Database Syst Rev (2010) 0.76
The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall Med (2011) 5.19
Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut (2002) 4.01
Impact of surgery for stress incontinence on morbidity: cohort study. BMJ (1997) 3.70
Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008. Ultraschall Med (2008) 3.49
Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases. Radiother Oncol (1986) 3.07
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. Br J Cancer (2005) 2.85
Experimental study of starch-induced intraperitoneal adhesions. Br J Surg (1990) 2.63
How should we introduce clinical PET in the UK? The oncologists need to have a view. Clin Oncol (R Coll Radiol) (2004) 2.56
Hepatitis B virus produced by transfected Hep G2 cells causes hepatitis in chimpanzees. Proc Natl Acad Sci U S A (1987) 2.46
Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy. HIV Med (2000) 2.37
Simplified chromatographic separation of immunoglobulin M from G and its application to toxoplasma indirect immunofluorescence. J Clin Microbiol (1979) 2.22
Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 Study. Br J Cancer (2009) 2.13
Expression of cloned hepatitis B virus DNA in human cell cultures. Proc Natl Acad Sci U S A (1980) 2.08
Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res (1993) 1.97
Non-surgical management of early breast cancer in the United Kingdom: radiotherapy fractionation practices. Clinical Audit Sub-committee of the Faculty of Clinical Oncology, Royal College of Radiologists, and the Joint Council for Clinical Oncology. Clin Oncol (R Coll Radiol) (1995) 1.82
Guidelines for the use of contrast agents in ultrasound. January 2004. Ultraschall Med (2004) 1.68
The first case of Lassa fever imported from Mali to the United Kingdom, February 2009. Euro Surveill (2009) 1.63
Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials. Ann Oncol (2013) 1.59
Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin. N Engl J Med (1991) 1.58
Correlation between hypomethylation of DNA and expression of globin genes in Friend erythroleukemia cells. Eur J Biochem (1977) 1.57
Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology? Eur J Nucl Med (1997) 1.55
British urological surgery practice: 1. Prostate cancer. Br J Urol (1997) 1.53
The cost-effectiveness of wound management protocols of care. Br J Nurs (2000) 1.52
A simple technique for vascular control during hepatectomy: the half-Pringle. Am J Surg (2001) 1.51
An assessment of clinically optimal gold marker length and diameter for pelvic radiotherapy verification using an amorphous silicon flat panel electronic portal imaging device. Br J Radiol (2005) 1.50
Coping style and depression influence the healing of diabetic foot ulcers: observational and mechanistic evidence. Diabetologia (2010) 1.47
Staphylococcal IgE antibodies, hyperimmunoglobulinemia E and Staphylococcus aureus infections. N Engl J Med (1979) 1.47
Effect of neoadjuvant chemoradiotherapy on angiogenesis in oesophageal cancer. Br J Surg (2003) 1.46
Influence of dietary protein restriction on immune competence. II. Effect on lymphoid tissue. Clin Exp Immunol (1976) 1.40
HIV-associated eosinophilic pustular folliculitis: The first case reported in a woman. J Am Acad Dermatol (1996) 1.40
Postural hypotension: body fluid compartments and electrolytes. Age Ageing (1973) 1.40
Prevalence of and risk factors for HIV-associated neuropathy in Melbourne, Australia 1993-2006. HIV Med (2007) 1.40
Recognizing the feet as being at risk from pressure damage. Br J Nurs (2002) 1.38
Evaluation of quality of contents of general practice records. Br Med J (Clin Res Ed) (1984) 1.38
Age and height predict neuropathy risk in patients with HIV prescribed stavudine. Neurology (2009) 1.35
OPUS study: suicidal behaviour, suicidal ideation and hopelessness among patients with first-episode psychosis. One-year follow-up of a randomised controlled trial. Br J Psychiatry Suppl (2002) 1.35
Phenotypic and genotypic characterization of commonly used human prostatic cell lines. BJU Int (2000) 1.35
The acute toxicity of barium sulfate administered intragastrically. Can Med Assoc J (1966) 1.34
An EFSUMB introduction into Dynamic Contrast-Enhanced Ultrasound (DCE-US) for quantification of tumour perfusion. Ultraschall Med (2012) 1.29
The relationship between hypoalbuminaemia, tumour volume and the systemic inflammatory response in patients with colorectal liver metastases. Br J Cancer (2004) 1.27
Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trials. Br J Radiol (2003) 1.27
Levels of IL-6 and soluble IL-6 receptor are increased in HIV patients with a history of immune restoration disease after HAART. HIV Med (2002) 1.26
Parametric image reconstruction using spectral analysis of PET projection data. Phys Med Biol (1998) 1.26
Identification of protein-binding sites in the hepatitis B virus enhancer and core promoter domains. Mol Cell Biol (1988) 1.26
Expression of receptors for advanced glycation end products in peripheral occlusive vascular disease. Am J Pathol (1995) 1.24
The role of D-1 and D-2 receptors. Nature (1980) 1.24
Experimental congestive heart failure produced by rapid ventricular pacing in the dog: cardiac effects. Circulation (1987) 1.24
Helicobacter pylori and duodenal ulcer recurrence. Am J Gastroenterol (1992) 1.24
Short report: the effect of omeprazole on Helicobacter pylori and associated gastritis. Aliment Pharmacol Ther (1991) 1.23
The toxicity of inactivated bacteria and endotoxin in mice suffering from protein malnutrition. J Reticuloendothel Soc (1975) 1.23
bcl-2: role in epithelial differentiation and oncogenesis. Hum Pathol (1996) 1.23
Relationship between thermal dose and outcome in thermoradiotherapy treatments for superficial recurrences of breast cancer: data from a phase III trial. Int J Radiat Oncol Biol Phys (1997) 1.22
Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction. Int J Mol Med (2003) 1.21
CNS somatosensory-auditory interactions elicit or modulate tinnitus. Exp Brain Res (2003) 1.21
64Cu metabolism in Menkes and normal cultured skin fibroblasts. Pediatr Res (1978) 1.21
Immunohistochemical distribution of c-erbB-2 in infiltrating and in situ breast cancer. Int J Cancer (1988) 1.19
Doppler perfusion index: an interobserver and intraobserver reproducibility study. Radiology (1998) 1.18
Drug quantitation on a benchtop liquid chromatography-tandem mass spectrometry system. J Chromatogr A (1997) 1.15
Mitochondrial DNA depletion: mutations in thymidine kinase gene with myopathy and SMA. Neurology (2002) 1.14
Altered expression of genes involved in regulation of vitamin A metabolism, solute transportation, and cytoskeletal function in the androgen-insensitive tfm mouse testis. Endocrinology (2007) 1.14
Does physiological blood glucose control require an adaptive control strategy? IEEE Trans Biomed Eng (1987) 1.14
The direct calculation of parametric images from dynamic PET data using maximum-likelihood iterative reconstruction. Phys Med Biol (1997) 1.14
Compartment syndrome: a very rare but potentially lethal complication of prolonged pelvic surgery. Br J Urol (1996) 1.14
Cancer of unknown primary: progress in the search for improved and rapid diagnosis leading toward superior patient outcomes. Ann Oncol (2011) 1.13
Practice parameters for sigmoid diverticulitis. The Standards Task Force American Society of Colon and Rectal Surgeons. Dis Colon Rectum (1995) 1.12
Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis. HIV Med (2008) 1.12
Inhibition of dimethyl sulfoxide-stimulated Friend cell erythrodifferentiation by hydrocortisone and other steroids. Proc Natl Acad Sci U S A (1978) 1.11
Outcomes in controlled and comparative studies on non-healing wounds: recommendations to improve the quality of evidence in wound management. J Wound Care (2010) 1.09
Species composition and seasonal abundance of stink bugs (Hemiptera: Pentatomidae) in Louisiana soybean. Environ Entomol (2013) 1.09
Common HLA-B8-DR3 haplotype in Northern India is different from that found in Europe. Tissue Antigens (2002) 1.09
The response of protein-deficient mice to tetanus toxoid. Effects of antigen dose, adjuvants, period of deprivation and age on antibody production. Immunology (1977) 1.08
Functional food properties of non-digestable oligosaccharides. Br J Nutr (1999) 1.08
Recommended distributions for exposure factors frequently used in health risk assessment. Risk Anal (1994) 1.08
A prospective randomised trial of 4 Gy or 8 Gy single doses in the treatment of metastatic bone pain. Radiother Oncol (1992) 1.08
Does nebulized corticosteroid therapy have an effect on ammonia-induced pulmonary injury? J Toxicol Clin Toxicol (2000) 1.07
Eradicating Helicobacter pylori and symptoms of non-ulcer dyspepsia. BMJ (1991) 1.06
Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord blood. Bone Marrow Transplant (2000) 1.05
Characterization of RNA transcripts and virally coded proteins synthesized in mouse fibroblasts transfected with hepatitis B DNA: HBeAg synthesis in HBcAg-negative cells with active core-antigen genes. Biosci Rep (1983) 1.05
Plasma bioavailable interleukin-6 is elevated in human immunodeficiency virus-infected patients who experience herpesvirus-associated immune restoration disease after start of highly active antiretroviral therapy. J Infect Dis (2001) 1.05
Acute oral toxicity of sucrose. Toxicol Appl Pharmacol (1965) 1.03
Subcutaneous glucose monitoring by means of electrochemical sensors: fiction or reality? J Biomed Eng (1992) 1.03
Egrets as monitors of trace-metal contamination in wetlands of Pakistan. Arch Environ Contam Toxicol (2003) 1.03
Factors determining the effects of chronic protein-deficiency on antibody responses to sheep red blood cells and Brucella abortus vaccine in mice. Aust J Exp Biol Med Sci (1977) 1.02
The relationship between ApoE, TNFA, IL1a, IL1b and IL12b genes and HIV-1-associated dementia. HIV Med (2008) 1.01
Walking performance in people with diabetic neuropathy: benefits and threats. Diabetologia (2006) 1.01
Separation and characterization of proteins from green and etiolated shoots of rice (Oryza sativa L.): towards a rice proteome. Electrophoresis (1999) 1.01
Mechanism of the family 1 beta-glucosidase from Streptomyces sp: catalytic residues and kinetic studies. Biochemistry (2001) 1.00
Susceptibility to multiple sclerosis mediated by HLA-DRB1 is influenced by a second gene telomeric of the TNF cluster. Hum Immunol (1999) 1.00
Histological characteristics of the index lesion in whole-mount radical prostatectomy specimens: implications for focal therapy. Prostate Cancer Prostatic Dis (2010) 1.00
DNA cloned from the ayw subtype of hepatitis B virus. J Med Virol (1980) 1.00
Murine cytomegalovirus binds reversibly to mouse embryo fibroblasts: implications for quantitation and explanation of centrifugal enhancement. J Virol Methods (1988) 0.99
N-acetyl cysteine ameliorates ischemic renal failure. Am J Physiol (1997) 0.99
Epidemiological survey of central nervous system germ cell tumors in Canadian children. J Neurooncol (2006) 0.99
Measurement of functional recovery in individuals with acute anterior cruciate ligament rupture. Br J Sports Med (2005) 0.98
Single scan parameterization of space-variant point spread functions in image space via a printed array: the impact for two PET/CT scanners. Phys Med Biol (2011) 0.97
The role of early ¹⁸F-FDG PET/CT in prediction of progression-free survival after ⁹⁰Y radioembolization: comparison with RECIST and tumour density criteria. Eur J Nucl Med Mol Imaging (2012) 0.97
Benzene toxicity and risk assessment, 1972-1992: implications for future regulation. Environ Health Perspect (1993) 0.97
Evaluation of Ki-67 monoclonal antibody as prognostic indicator for prostatic carcinoma. Br J Urol (1993) 0.97